Suscribirse

Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control – A possible oversight link - 29/08/16

Doi : 10.1016/j.rmed.2016.07.004 
Jessica Han Ying Tan, Anne Ann Ling Hsu
 Department of Respiratory & Critical Care Medicine, Singapore General Hospital, Singapore 

Corresponding author. Department of Respiratory & Critical Care Medicine, Singapore General Hospital, College Road, Academia, Level 3, Singapore.Department of Respiratory & Critical Care MedicineSingapore General HospitalCollege RoadAcademia, Level 3Singapore

Abstract

Background

Patients with aspirin-exacerbated respiratory disease (AERD) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (NERD) must avoid aspirin and all other oral NSAIDs. The effect of topical NSAID (tNSAID), especially salicylates which are commonly present in topical medicated preparations, on asthma control of this phenotype is studied.

Methods

The study inclusion criteria were adults with: 1) NSAID hypersensitivity; 2) nasal polyposis/chronic rhinosinusitis; 3) not well-/poorly controlled asthma and 4) exposure to tNSAID. Patients were given verbal and written instructions to cease tNSAIDs exposure and asthma control was evaluated during the 6 months prior and after intervention.

Results

There were eleven patients (ten females) with a mean age of 56.5 (range 37–71) years. Prior known oral NSAIDs hypersensitivity included aspirin (5), mefenamic acid (2), diclofenac (2), Synflex (2) and ibuprofen (1). All, except 2, had arthropathies or spinal disorders and were using tNSAID for a mean of 4.2 years. One, four and six patients were using over-the-counter medicated oil containing salicylates, NSAID gel/plasters and both respectively. All patients had cutaneous, with 4 having concomitant inhalational exposure to these tNSAIDs. The mean duration of asthma diagnosis and uncontrolled asthma were 25.2 and 4.5 years respectively. Except for 2 patients, there was no change in asthma maintenance medications pre and post-intervention. Asthma control significantly (p < 0.05) improved based on pre and post-intervention ACT score, number of exacerbations, FEV1 were 14.9 and 22.1, 1.9 and 0.43, 1.28L and 1.67L respectively.

Conclusions

It is paramount to eliminate not only oral but topical NSAID exposure in NERD phenotype asthmatic patients. When a long-standing asthma progressed to uncontrolled, a meticulous evaluation of tNSAIDs exposure is warranted especially if the patient has developed chronic pain.

El texto completo de este artículo está disponible en PDF.

Highlights

Patients with NERD phenotype asthma should avoid all NSAIDs with COX-1 inhibitors.
It is paramount to eliminate not only systemic but also topical NSAID exposure.
A meticulous evaluation for topical NSAID exposure is warranted for uncontrolled or severe asthma.
Simple avoidance intervention can reduce the morbidity burden.

El texto completo de este artículo está disponible en PDF.

Keywords : Aspirin-exacerbated respiratory disease, Non-steroidal anti-inflammatory drug hypersensitivity


Esquema


© 2016  Elsevier Ltd. Reservados todos los derechos.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 118

P. 1-3 - septembre 2016 Regresar al número
Artículo precedente Artículo precedente
  • Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity
  • Alice Gallo de Moraes, Abhay Vakil, Teng Moua
| Artículo siguiente Artículo siguiente
  • Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014
  • Ramón Suárez-Medina, Silvia Josefina Venero-Fernández, John Britton, Andrew W. Fogarty

¿Ya suscrito a @@106933@@ revista ?